TITLE

New developments in intermittent claudication

AUTHOR(S)
Stansby, Gerard
PUB. DATE
April 2005
SOURCE
Pulse;4/30/2005, Vol. 65 Issue 17, p57
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article cites new developments in intermittent claudication (IC). Background IC is often the first symptom of peripheral arterial disease and is usually due to widespread atherosclerosis. However, IC symptoms often go unreported by patients since they assume the cramp-like pain on walking to be a sign of ageing or arthritis. The pain is usually felt in the calves, although it can occur in the buttocks or thighs, after exercise. If the patient stops and rests, the pain disappears, but returns when they begin walking again.
ACCESSION #
17053267

 

Related Articles

  • NEW CLINICAL APPROACH TO THE MANAGEMENT OF INTERMITTENT CLAUDICATION (ANGINA CRURIS). Samuels, Saul S.; Shaftel, Herbert E. // Angiology;Dec1958, Vol. 9 Issue 6, p378 

    Examines a clinical approach to the management of intermittent claudication or angina cruris. Consideration of plethysmographic studies in judging the effect of vasodilating drugs on the peripheral circulation; Importance of supplementing vasodilators with tranquilizers; Description of the...

  • A TWO-STEP TEST OF EXERCISE TOLERANCE IN INTERMITTENT CLAUDICATION. Kissin, Milton; Steix, Julius J.; Adleman, Ralph J. // Angiology;Apr1950, Vol. 1 Issue 2, p141 

    A two-step stair climbing test was found to be a satisfactory and convenient measure of exercise tolerance in intermittent claudication. The patient walked back and forth over a set of steps until pain appeared in the leg. The number of trips made over the steps was recorded as the exercise...

  • The low down on claudicant leg pain. Targett, Steve // New Zealand Doctor;6/14/2006, p34 

    Presents information on claudicant leg pain. Description of the leg pain; Causes; Treatment.

  • The prognostic impact of general and abdominal obesity in peripheral arterial disease. Giugliano, G.; Brevetti, G.; Laurenzano, E.; Brevetti, L.; Luciano, R.; Chiariello, M. // International Journal of Obesity;Feb2010, Vol. 34 Issue 2, p280 

    Objective:Obesity is an independent cardiovascular risk factor, but its prognostic role in patients with peripheral arterial disease (PAD) is not well defined. Accordingly, we assessed the impact of body mass index (BMI) and waist circumference (WC) on cardiovascular risk in a homogeneous cohort...

  • Cystic Adventitial Disease of the Popliteal Artery: A Case Report. Harjola, Pekka-T.; Ketonen, Pentti; Ala-Kulju, Kari // Vascular Surgery;Sep/Oct1985, Vol. 19 Issue 5, p366 

    A case of intermittent claudication in a young otherwise healthy non-smoker caused by cystic adventitial disease of the popliteal artery is presented. Other possible causes of calf claudication in a young non-smoker as well as etiology, clinical findings and modes of operative treatment are...

  • Update on Thromboangiitis Obliterans (Buerger's Disease). Kirchner, Jeffrey T. // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1195 

    Presents a study by J.W. Olin on the current concepts of thromboangiitis obliterans, also known as Buerger's disease. Description of the study and its results; Effective treatment methods.

  • Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795 

    The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...

  • Treatment of Patients with Thromboangiitis Obliterans with Cyclophosphamide. Saha, Kunal; Chabra, Navdeep; Gulati, Surindra Mohan // Angiology;Jun2001, Vol. 52 Issue 6 

    Describes a small, nonrandomized trial of cyclophosphamide in the treatment of patients with advanced thromboangiitis obliterans with modest results. Basis of the rationale of the treatment; Basis of diagnosis; Improvement of the clinical condition of the patient during and after the treatment;...

  • LONG-TERM ANTICOAGULANT THERAPY IN THE TREATMENT OF INTERMITTENT CLAUDICATION. Milnés-López, Bernardo; Carrillo, Pedro; Toledo, Fernando; McCook, George // Angiology;Dec1957, Vol. 8 Issue 6, p534 

    Discusses the long-term anticoagulant therapy in the treatment of intermittent claudication. Evaluation of intermittent claudication; Effect of long continued anticoagulant therapy on intermittent claudication; Degree of improvement of the treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics